Recently, the Diabetes drug Avandia was discovered to be a contributing factor in the increased risk of heart attacks and heart problems in diabetics to whom the drug was administered. There may be evidence that the FDA (Food and Drug Administration) and Glaxo (the manufacturer) knew about these potential risks. Additionally, women taking Avandia have suffered an increased risk of a specific type of visual abnormality can 'macular edema', as well as increased risk of fractures.
Studies show that Avandia is not as effective as some other, more proven, drugs for lowering blood sugar or controlling glucose production. Avandia is designed to work by decreasing sugar production, then assisting the body in making more efficient use of the insulin that is available. However, despite serious cardiovascular risks and cardiac-related deaths, Avandia continues to be prescribed. The FDA's solution was to compel Glaxo to attach a 'black box' warning to the prescription; the most stringent warning a prescription drug can carry. On May 21, 2007, the FDA issued an immediate public safety alert, advising Avandia users to consult with their doctors regarding their cardiac risk.
Additional Risks Associated with Avandia:
- Fluid retention, swelling, weight gain and potential heart failure
- Swelling
- Low blood sugar
- Fractures
- Weight gain
- Low red blood cell count
- Ovulation leading to pregnancy
- Liver problems
- Cold-like symptoms
- Headache
If Avandia was prescribed for you or a loved one and an Avandia-related injury or death occurred, you may be able to file a lawsuit.
The experienced New Jersey law firm of Anapol Schwartz is highly skilled in pursuing your claim. Our seasoned South Jersey Avandia attorneys are well aware of the issues surrounding Avandia use, and are standing by to assist you in investigating your claim and determining if you have a legal right to compensation.
Please contact our office to schedule a confidential, free consultation with a competent attorney, or complete our free case evaluation online.
